Human Epilepsy Genetics--Neuronal Migration Disorders Study

Sponsor
Harvard University Faculty of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT00041600
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (NIH), Howard Hughes Medical Institute (Other)
3,500
1
410
8.5

Study Details

Study Description

Brief Summary

The purpose of this study is to identify genes responsible for epilepsy and disorders of human cognition.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Epilepsy is responsible for tremendous long-term healthcare costs. Analysis of inherited epilepsy conditions has allowed for identification of several key genes active in the developing brain. Although many genetic abnormalities of the brain are rare and lethal, rapidly advancing knowledge of the structure of the human genome makes it a realistic goal to identify genes responsible for several other epileptic conditions.

    The purpose of this study is to identify genes responsible for epilepsy and disorders of human cognition (EDHC). The Walsh Laboratory at the Children's Hospital Boston and Beth Israel Deaconess Medical Center is looking for genes involved in brain development. Conditions that we study include brain malformations, such as polymicrogyria, lissencephaly, Walker-Warburg syndrome, heterotopias, and cerebellar hypoplasia, and inherited disorders of cognition, such as familial mental retardation and familial autism; people with these conditions also often have epilepsy. The structural brain abnormalities are usually diagnosed by brain MRI or sometimes CT scans. Adults and children with these conditions, and their family members, are invited to participate in our study. By comparing the DNA of individuals or families that carry EDHC to the DNA of people in the general population, it may be possible to learn more about the genetic bases of certain forms of EDHC.

    Study participants must have a brain malformation or disorder of cognition such as mental retardation or autism in addition to epilepsy in order to take part in this research.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    3500 participants
    Observational Model:
    Family-Based
    Time Perspective:
    Other
    Official Title:
    Human Epilepsy Genetics--Neuronal Migration Disorders Study
    Study Start Date :
    Apr 1, 1996
    Anticipated Primary Completion Date :
    Jun 1, 2030
    Anticipated Study Completion Date :
    Jun 1, 2030

    Outcome Measures

    Primary Outcome Measures

    1. Identification and characterization of genes important in normal brain development and associated with congenital brain malformations. [Ongoing]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    INCLUSION:
    • Males and females of any age.

    • Persons with a brain malformation or disorder of cognition (intellectual disability [previously known as mental retardation] or autism).

    EXCLUSION:
    • Persons without a brain malformation or disorder of cognition (intellectual disability (previously known as mental retardation] or autism).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Boston Children's Hospital, Walsh Laboratory Boston Massachusetts United States 02115

    Sponsors and Collaborators

    • Harvard University Faculty of Medicine
    • National Institute of Neurological Disorders and Stroke (NINDS)
    • Howard Hughes Medical Institute

    Investigators

    • Principal Investigator: Christopher A. Walsh, M.D., Ph.D., Harvard Institutes of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Dr. Chris Walsh, Investigator, Harvard University Faculty of Medicine
    ClinicalTrials.gov Identifier:
    NCT00041600
    Other Study ID Numbers:
    • R01NS035129
    First Posted:
    Jul 12, 2002
    Last Update Posted:
    Mar 21, 2022
    Last Verified:
    Mar 1, 2022

    Study Results

    No Results Posted as of Mar 21, 2022